Basic Information
| LncRNA/CircRNA Name | LINC00461 |
| Synonyms | NA |
| Region | GRCh38_5:88507546-88691041 |
| Ensemble | ENSG00000245526 |
| Refseq | NR_024384 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | renal cell carcinoma |
| ICD-0-3 | C64.9 |
| Methods | RNA-seq, qPCR |
| Sample | glioma tissues,cell line(OS-RC-2 ) |
| Expression Pattern | up-regulated |
| Function Description | The expression level of LINC00461 was also significantly increased in the miR-942-transfected group |
| Pubmed ID | 31545458 |
| Year | 2019 |
| Title | LINC00461 affects the survival of patients with renal cell carcinoma by acting as a competing endogenous RNA for microRNA-942. |
External Links
| Links for LINC00461 | GenBank HGNC NONCODE |
| Links for renal cell carcinoma | OMIM COSMIC |